{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T12:14:40Z","timestamp":1772453680389,"version":"3.50.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2018,2,16]],"date-time":"2018-02-16T00:00:00Z","timestamp":1518739200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1007\/s10067-018-4032-3","type":"journal-article","created":{"date-parts":[[2018,2,16]],"date-time":"2018-02-16T18:57:31Z","timestamp":1518807451000},"page":"1257-1263","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["The clinical phenotype of patients positive for antibodies to myositis and myositis-related disorders"],"prefix":"10.1007","volume":"37","author":[{"given":"S. G.","family":"Gofrit","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Yonath","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Lidar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Shoenfeld","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Kivity","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,2,16]]},"reference":[{"key":"4032_CR1","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1093\/rheumatology\/keu289","volume":"54","author":"A Meyer","year":"2015","unstructured":"Meyer A, Meyer N, Schaeffer M, Gottenberg JE, Geny B, Sibilia J (2015) Incidence and prevalence of inflammatory myopathies: a systematic review. Rheumatology 54:50\u201363. \n                    https:\/\/doi.org\/10.1093\/rheumatology\/keu289","journal-title":"Rheumatology"},{"key":"4032_CR2","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1136\/annrheumdis-2013-205127","volume":"74","author":"C Dobloug","year":"2015","unstructured":"Dobloug C, Garen T, Bitter H et al (2015) Prevalence and clinical characteristics of adult polymyositis and dermatomyositis; data from a large and unselected Norwegian cohort. Ann Rheum Dis 74:1551\u20131556. \n                    https:\/\/doi.org\/10.1136\/annrheumdis-2013-205127","journal-title":"Ann Rheum Dis"},{"key":"4032_CR3","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1111\/ene.12627","volume":"22","author":"GC Dobloug","year":"2015","unstructured":"Dobloug GC, Antal EA, Sveberg L, Garen T, Bitter H, Stj\u00e4rne J, Gr\u00f8vle L, Gran JT, Molberg \u00d8 (2015) High prevalence of inclusion body myositis in Norway; a population-based clinical epidemiology study. Eur J Neurol 22:672\u2013e41. \n                    https:\/\/doi.org\/10.1111\/ene.12627","journal-title":"Eur J Neurol"},{"key":"4032_CR4","doi-asserted-by":"publisher","DOI":"10.1007\/s11926-013-0335-1","volume":"15","author":"A Ghirardello","year":"2013","unstructured":"Ghirardello A, Bassi N, Palma L, Borella E, Domeneghetti M, Punzi L, Doria A (2013) Autoantibodies in polymyositis and dermatomyositis. Curr Rheumatol Rep 15:335. \n                    https:\/\/doi.org\/10.1007\/s11926-013-0335-1","journal-title":"Curr Rheumatol Rep"},{"key":"4032_CR5","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1186\/ar389","volume":"4","author":"R Brouwer","year":"2002","unstructured":"Brouwer R, Vree Egberts WTM, Hengstman GJD, Raijmakers R, van Engelen BGM, Peter Seelig H, Renz M, Mierau R, Genth E, Pruijn GJM, van Venrooij WJ (2002) Autoantibodies directed to novel components of the PM\/Scl complex, the human exosome. Arthritis Res 4:134\u2013138. \n                    https:\/\/doi.org\/10.1186\/ar389","journal-title":"Arthritis Res"},{"key":"4032_CR6","doi-asserted-by":"publisher","first-page":"2148","DOI":"10.1101\/gad.13.16.2148","volume":"13","author":"C Allmang","year":"1999","unstructured":"Allmang C, Petfalski E, Podtelejnikov A, Mann M, Tollervey D, Mitchell P (1999) The yeast exosome and human PM-Scl are related complexes of 3\u2032\u21925\u2032 exonucleases. Genes Dev 13:2148\u20132158. \n                    https:\/\/doi.org\/10.1101\/gad.13.16.2148","journal-title":"Genes Dev"},{"key":"4032_CR7","doi-asserted-by":"publisher","first-page":"331","DOI":"10.3389\/fimmu.2015.00331","volume":"6","author":"TIG La De","year":"2015","unstructured":"De La TIG (2015) Clinical usefulness of autoantibodies in idiopathic inflammatory myositis. Front Immunol 6:331. \n                    https:\/\/doi.org\/10.3389\/fimmu.2015.00331","journal-title":"Front Immunol"},{"key":"4032_CR8","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1186\/ar3275","volume":"13","author":"ZE Betteridge","year":"2011","unstructured":"Betteridge ZE, Gunawardena H, McHugh NJ (2011) Novel autoantibodies and clinical phenotypes in adult and juvenile myositis. Arthritis Res Ther 13:209. \n                    https:\/\/doi.org\/10.1186\/ar3275","journal-title":"Arthritis Res Ther"},{"key":"4032_CR9","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/S0092-8674(00)81758-4","volume":"95","author":"Y Zhang","year":"1998","unstructured":"Zhang Y, LeRoy G, Seelig HP, Lane WS, Reinberg D (1998) The dermatomyositis-specific autoantigen Mi2 is a component of a complex containing histone deacetylase and nucleosome remodeling activities. Cell 95:279\u2013289. \n                    https:\/\/doi.org\/10.1016\/S0092-8674(00)81758-4","journal-title":"Cell"},{"key":"4032_CR10","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.autrev.2014.01.022","volume":"13","author":"M Mahler","year":"2014","unstructured":"Mahler M, Miller FW, Fritzler MJ (2014) Idiopathic inflammatory myopathies and the anti-synthetase syndrome: a comprehensive review. Autoimmun Rev 13:367\u2013371. \n                    https:\/\/doi.org\/10.1016\/j.autrev.2014.01.022","journal-title":"Autoimmun Rev"},{"key":"4032_CR11","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1002\/art.1780330908","volume":"33","author":"IN Targoff","year":"1990","unstructured":"Targoff IN, Johnson AE, Miller FW (1990) Antibody to signal recognition particle in polymyositis. Arthritis Rheum 33:1361\u20131370. \n                    https:\/\/doi.org\/10.1002\/art.1780330908","journal-title":"Arthritis Rheum"},{"key":"4032_CR12","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1002\/art.1780390521","volume":"39","author":"R Mierau","year":"1996","unstructured":"Mierau R, Dick T, Bartz-Bazzanella P, Keller E, Albert ED, Genth E (1996) Strong association of dermatomyositis-specific Mi-2 autoantibodies with a tryptophan at position 9 of the HLA-DR beta chain. Arthritis Rheum 39:868\u2013876. \n                    https:\/\/doi.org\/10.1002\/art.1780390521","journal-title":"Arthritis Rheum"},{"key":"4032_CR13","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1093\/rheumatology\/kep455","volume":"49","author":"B Hervier","year":"2010","unstructured":"Hervier B, Wallaert B, Hachulla E, Adoue D, Lauque D, Audrain M, Camara B, Fournie B, Couret B, Hatron PY, Dubucquoi S, Hamidou M (2010) Clinical manifestations of anti-synthetase syndrome positive for anti-alanyl-tRNA synthetase (anti-PL12) antibodies: a retrospective study of 17 cases. Rheumatology (Oxford) 49:972\u2013976. \n                    https:\/\/doi.org\/10.1093\/rheumatology\/kep455","journal-title":"Rheumatology (Oxford)"},{"key":"4032_CR14","doi-asserted-by":"crossref","unstructured":"Marguerie C, Bunn CC, Beynon HLC, et al (1990) Polymyositis, pulmonary fibrosis and autoantibodies to aminoacyl-tRNA synthetase enzymes. 1019\u20131038","DOI":"10.1093\/qjmed\/77.1.1019"},{"key":"4032_CR15","doi-asserted-by":"publisher","first-page":"2907","DOI":"10.1183\/09031936.97.10122907","volume":"10","author":"A Sauty","year":"1997","unstructured":"Sauty A, Rochat T, Schoch OD, Hamacher J, Kurt AM, Dayer JM, Nicod LP (1997) Pulmonary fibrosis with predominant CD8 lymphocytic alveolitis and anti-jo-1 antibodies. Eur Respir J 10:2907\u20132912. \n                    https:\/\/doi.org\/10.1183\/09031936.97.10122907","journal-title":"Eur Respir J"},{"key":"4032_CR16","doi-asserted-by":"publisher","first-page":"R78","DOI":"10.1186\/ar2276","volume":"9","author":"M Koenig","year":"2007","unstructured":"Koenig M, Fritzler MJ, Targoff IN, Troyanov Y, Sen\u00e9cal JL (2007) Heterogeneity of autoantibodies in 100 patients with autoimmune myositis: insights into clinical features and outcomes. Arthritis Res Ther 9:R78. \n                    https:\/\/doi.org\/10.1186\/ar2276","journal-title":"Arthritis Res Ther"},{"key":"4032_CR17","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1080\/08916930600622884","volume":"39","author":"H Yoshifuji","year":"2006","unstructured":"Yoshifuji H, Fujii T, Kobayashi S, Imura Y, Fujita Y, Kawabata D, Usui T, Tanaka M, Nagai S, Umehara H, Mimori T (2006) Anti-aminoacyl-tRNA synthetase antibodies in clinical course prediction of interstitial lung disease complicated with idiopathic inflammatory myopathies. Autoimmunity 39:233\u2013241. \n                    https:\/\/doi.org\/10.1080\/08916930600622884","journal-title":"Autoimmunity"},{"key":"4032_CR18","doi-asserted-by":"publisher","first-page":"3125","DOI":"10.1002\/art.22865","volume":"56","author":"KB Stone","year":"2007","unstructured":"Stone KB, Oddis CV, Fertig N, Katsumata Y, Lucas M, Vogt M, Domsic R, Ascherman DP (2007) Anti-Jo-1 antibody levels correlate with disease activity in idiopathic inflammatory myopathy. Arthritis Rheum 56:3125\u20133131. \n                    https:\/\/doi.org\/10.1002\/art.22865","journal-title":"Arthritis Rheum"},{"key":"4032_CR19","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1002\/art.1780280711","volume":"28","author":"IN Targoff","year":"1985","unstructured":"Targoff IN, Reichlin M (1985) The association between Mi-2 antibodies and dermatomyositis. Arthritis Rheum 28:796\u2013803. \n                    https:\/\/doi.org\/10.1002\/art.1780280711","journal-title":"Arthritis Rheum"},{"key":"4032_CR20","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1080\/08916930400022681","volume":"38","author":"A Ghirardello","year":"2005","unstructured":"Ghirardello A, Zampieri S, Iaccarino L, Tarricone E, Bendo* R, Gambari PF, Doria A (2005) Anti-Mi-2 antibodies. Autoimmunity 38:79\u201383. \n                    https:\/\/doi.org\/10.1080\/08916930400022681","journal-title":"Autoimmunity"},{"key":"4032_CR21","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1183\/09031936.00104310","volume":"37","author":"B Hervier","year":"2011","unstructured":"Hervier B, Uzunhan Y, Hachulla E, Benveniste O, Nunes H, Delaval P, Musset L, Dubucquoi S, Wallaert B, Hamidou M (2011) Antisynthetase syndrome positive for anti-threonyl-tRNA synthetase (anti-PL7) antibodies. Eur Respir J 37:714\u2013717. \n                    https:\/\/doi.org\/10.1183\/09031936.00104310","journal-title":"Eur Respir J"},{"key":"4032_CR22","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/j.ejim.2013.01.002","volume":"24","author":"I Marie","year":"2013","unstructured":"Marie I, Josse S, Decaux O, Diot E, Landron C, Roblot P, Jouneau S, Hatron PY, Hachulla E, Vittecoq O, Menard JF, Jouen F, Dominique S (2013) Clinical manifestations and outcome of anti-PL7 positive patients with antisynthetase syndrome. Eur J Intern Med 24:474\u2013479. \n                    https:\/\/doi.org\/10.1016\/j.ejim.2013.01.002","journal-title":"Eur J Intern Med"},{"key":"4032_CR23","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1097\/MD.0b013e318260977c","volume":"91","author":"A Labirua-Iturburu","year":"2012","unstructured":"Labirua-Iturburu A, Selva-O\u2019Callaghan A, Vincze M, Dank\u00f3 K, Vencovsky J, Fisher B, Charles P, Dastmalchi M, Lundberg IE (2012) Anti-PL-7 (anti-threonyl-tRNA synthetase) antisynthetase syndrome: clinical manifestations in a series of patients from a European multicenter study (EUMYONET) and review of the literature. Med 91:206\u2013211. \n                    https:\/\/doi.org\/10.1097\/MD.0b013e318260977c","journal-title":"Med"},{"key":"4032_CR24","doi-asserted-by":"publisher","first-page":"2004","DOI":"10.1002\/art.21883","volume":"54","author":"Y Yamasaki","year":"2006","unstructured":"Yamasaki Y, Yamada H, Nozaki T, Akaogi J, Nichols C, Lyons R, Chin Loy A, Chan EKL, Reeves WH, Satoh M (2006) Unusually high frequency of autoantibodies to PL-7 associated with milder muscle disease in Japanese patients with polymyositis\/dermatomyositis. Arthritis Rheum 54:2004\u20132009. \n                    https:\/\/doi.org\/10.1002\/art.21883","journal-title":"Arthritis Rheum"},{"key":"4032_CR25","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/S0049-0172(96)80026-6","volume":"26","author":"W Friedman a","year":"1996","unstructured":"Friedman a W, Targoff IN, Arnett FC (1996) Interstitial lung disease with autoantibodies against aminoacyl-tRNA synthetases in the absence of clinically apparent myositis. Semin Arthritis Rheum 26:459\u2013467. \n                    https:\/\/doi.org\/10.1016\/S0049-0172(96)80026-6","journal-title":"Semin Arthritis Rheum"},{"key":"4032_CR26","first-page":"1393","volume":"29","author":"F Franceschini","year":"2002","unstructured":"Franceschini F, Cavazzana I, Generali D, Quinzanini M, Viardi L, Ghirardello A, Doria A, Cattaneo R (2002) Anti-Ku antibodies in connective tissue diseases: clinical and serological evaluation of 14 patients. J Rheumatol 29:1393\u20131397","journal-title":"J Rheumatol"},{"key":"4032_CR27","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1177\/0961203308089442","volume":"17","author":"I Cavazzana","year":"2008","unstructured":"Cavazzana I, Ceribelli A, Quinzanini M, Scarsi M, Air\u00f2 P, Cattaneo R, Franceschini F (2008) Prevalence and clinical associations of anti-Ku antibodies in systemic autoimmune diseases. Lupus 17:727\u2013732. \n                    https:\/\/doi.org\/10.1177\/0961203308089442","journal-title":"Lupus"},{"key":"4032_CR28","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1016\/S0889-857X(02)00021-2","volume":"28","author":"FL Mastaglia","year":"2002","unstructured":"Mastaglia FL, Phillips BA (2002) Idiopathic inflammatory myopathies: epidemiology, classification, and diagnostic criteria. Rheum Dis Clin N Am 28:723\u2013741. \n                    https:\/\/doi.org\/10.1016\/S0889-857X(02)00021-2","journal-title":"Rheum Dis Clin N Am"},{"key":"4032_CR29","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s10067-014-2512-7","volume":"34","author":"SK Basnayake","year":"2015","unstructured":"Basnayake SK, Blumbergs P, Tan JA et al (2015) Inflammatory myopathy with anti-SRP antibodies: case series of a South Australian cohort. Clin Rheumatol 34:603\u2013608. \n                    https:\/\/doi.org\/10.1007\/s10067-014-2512-7","journal-title":"Clin Rheumatol"},{"key":"4032_CR30","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1136\/ard.2006.052191","volume":"65","author":"GJ Hengstman","year":"2006","unstructured":"Hengstman GJ, ter Laak HJ, Vree Egberts WT et al (2006) Anti-signal recognition particle autoantibodies: marker of a necrotising myopathy. Ann Rheum Dis 65:1635\u20131638. \n                    https:\/\/doi.org\/10.1136\/ard.2006.052191","journal-title":"Ann Rheum Dis"},{"key":"4032_CR31","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-015-0277-y","volume":"10","author":"S Suzuki","year":"2015","unstructured":"Suzuki S, Nishikawa A, Kuwana M, Nishimura H, Watanabe Y, Nakahara J, Hayashi YK, Suzuki N, Nishino I (2015) Inflammatory myopathy with anti-signal recognition particle antibodies: case series of 100 patients. Orphanet J Rare Dis 10:61. \n                    https:\/\/doi.org\/10.1186\/s13023-015-0277-y","journal-title":"Orphanet J Rare Dis"},{"key":"4032_CR32","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.jbspin.2015.12.005","volume":"84","author":"S Rodr\u00edguez-Muguruza","year":"2017","unstructured":"Rodr\u00edguez-Muguruza S, Lozano-Ramos I, Canti JC et al (2017) Anti-SRP auto-antibodies are not specific for myositis: report of 8 cases. Joint Bone Spine 84:103\u2013105. \n                    https:\/\/doi.org\/10.1016\/j.jbspin.2015.12.005","journal-title":"Joint Bone Spine"},{"key":"4032_CR33","first-page":"918","volume":"34","author":"C Martel","year":"2016","unstructured":"Martel C, Vignaud G, Liozon E, Magy L, Gallouedec G, Ly K, Bezanahary H, Cypierre A, Lap\u00e9bie FX, Palat S, Gondran G, Jauberteau MO, Fauchais AL (2016) Contribution of dot-blot assay to the diagnosis and management of myositis: a three-year practice at a university hospital centre. Clin Exp Rheumatol 34:918\u2013924","journal-title":"Clin Exp Rheumatol"},{"key":"4032_CR34","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1002\/acr.21985","volume":"65","author":"Z Chen","year":"2013","unstructured":"Chen Z, Cao M, Plana MN, Liang J, Cai H, Kuwana M, Sun L (2013) Utility of anti-melanoma differentiation-associated gene 5 antibody measurement in identifying patients with dermatomyositis and a high risk for developing rapidly progressive interstitial lung disease: a review of the literature and a meta-analysis. Arthritis Care Res 65:1316\u20131324. \n                    https:\/\/doi.org\/10.1002\/acr.21985","journal-title":"Arthritis Care Res"},{"key":"4032_CR35","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/j.amjmed.2009.11.012","volume":"123","author":"A Selva-O\u2019Callaghan","year":"2010","unstructured":"Selva-O\u2019Callaghan A, Grau JM, G\u00e1mez-Cenzano C et al (2010) Conventional cancer screening versus PET\/CT in dermatomyositis\/polymyositis. Am J Med 123:558\u2013562. \n                    https:\/\/doi.org\/10.1016\/j.amjmed.2009.11.012","journal-title":"Am J Med"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-018-4032-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-018-4032-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-018-4032-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,2,17]],"date-time":"2019-02-17T02:41:14Z","timestamp":1550371274000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-018-4032-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,16]]},"references-count":35,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["4032"],"URL":"https:\/\/doi.org\/10.1007\/s10067-018-4032-3","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,16]]},"assertion":[{"value":"14 December 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 February 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethical considerations are detailed in methods.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}